The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. NewAmsterdam Pharma Company NV shares valued at $834,440 were sold by ForGrowth NAP B.V. on Nov 18 ’24. At $25.08 per share, ForGrowth NAP B.V. sold 33,273 shares. The insider’s holdings dropped to 11,778,760 shares worth approximately $215.2 million following the completion of this transaction.
Also, ForGrowth NAP B.V. sold 8,530 shares, netting a total of over 213,436 in proceeds. Following the sale of shares at $25.02 each, the insider now holds 11,812,033 shares.
Before that, ForGrowth NAP B.V. had sold 9,832 shares from its account. In a trade valued at $245,856, the 10% Owner traded NewAmsterdam Pharma Company NV shares for $25.01 each. Upon closing the transaction, the insider’s holdings decreased to 9,832 shares, worth approximately $215.96 million.
As published in their initiating research note from TD Cowen on May 15, 2024, NewAmsterdam Pharma Company NV [NAMS] has been a Buy. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in mid March. As of January 18, 2024, Guggenheim has initiated its “Buy” rating for NAMS. Earlier on January 16, 2024, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for NAMS stock.
Analyzing NAMS Stock Performance
During the last five days, there has been a drop of approximately -12.33%. Over the course of the year, NewAmsterdam Pharma Company NV shares have jumped approximately 63.56%. Shares of the company reached a 52-week high of $26.35 on 01/25/24 and a 52-week low of $11.18 on 01/02/24. A 50-day SMA is recorded $19.67, while a 200-day SMA reached $19.48. Nevertheless, trading volume fell to 1.1 million shares from 0.59 million shares the previous day.
Support And Resistance Levels for NewAmsterdam Pharma Company NV (NAMS)
According to the 24-hour chart, there is a support level at 17.50, which, if violated, would cause prices to drop to 16.72. In the upper region, resistance lies at 19.51. The next price resistance is at 20.74. RSI (Relative Strength Index) is 36.49 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.06, which suggests the price will decrease in the coming days. Percent R is at 95.79%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
